Lv1
40 积分 2023-11-07 加入
Prognostic impact of variant allele frequency in intensively treated patients with NPM1-mutated AML: a PETHEMA study
13小时前
已完结
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics
2个月前
已完结
XPO1 drives resistance to eprenetapopt and azacitidine and can be targeted in TP53 -mutated myeloid malignancies
3个月前
已完结
Treatment for relapsed acute promyelocytic leukemia
4个月前
已完结
Acute Promyelocytic Leukemia
4个月前
已完结
The earliest thymic progenitors for T cells possess myeloid lineage potential
5个月前
已完结
Venetoclax combined with azacitidine as an effective and safe salvage regimen for relapsed or refractory T-cell acute lymphoblastic leukemia: a case series
5个月前
已完结
Venetoclax plus azacitidine in relapsed or refractory T-cell acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 trial
6个月前
已完结
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes
11个月前
已完结